Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia.
about
Muscle wasting in animal models of severe illnessThe role of cytokines in cancer cachexia.Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditionsTumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.The role of cytokines in muscle wasting: its relation with cancer cachexia.Chemotherapeutic Efficacy of Indigofera aspalathoides on 20-Methylcholanthrene-Induced Fibrosarcoma in RatsHumoral mediation for cachexia in tumour-bearing rats.Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexiaPerturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).The cancer cachexia syndrome: a review of metabolic and clinical manifestations.Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.STAT3 in the systemic inflammation of cancer cachexia.Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.A leucine-rich diet modulates the tumor-induced down-regulation of the MAPK/ERK and PI3K/Akt/mTOR signaling pathways and maintains the expression of the ubiquitin-proteasome pathway in the placental tissue of NMRI mice.Antiproliferative role of Indigofera aspalathoides on 20 methylcholanthrene induced fibrosarcoma in rats.Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.The ubiquitin system: a role in disease?The metabolic basis of cancer cachexia.Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).Protein and Amino Acid Supplementation Does Not Alter Proteolytic Gene Expression following Immobilization.Tumour growth results in changes in placental amino acid transport in the rat: a tumour necrosis factor alpha-mediated effect.Pharmacological interference with tissue hypercatabolism in tumour-bearing ratsActivation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia.Protein metabolism in the tumour-bearing mouse. Rates of protein synthesis in host tissues and in an Ehrlich ascites tumour at different stages in tumour growth.Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.Hepatic transport of gluconeogenic substrates during tumor growth in the rat.Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia?Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation–contraction coupling together with additional muscle alterations.Leptin and tumor growth in rats.Patterns of gene expression in muscle and fat in tumor-bearing rats: effects of CRF2R agonist on cachexia.Nutritional treatment of cancer cachexia in rats
P2860
Q27000450-512A2317-6D4D-45F8-99B6-5909EA1AB7F5Q33610662-E1A5BBA0-D565-45C7-B05C-58926DD3400BQ33804521-7D0A5E81-69B9-46B3-9009-D6D5969CAC1BQ33909897-63AE5128-A64C-4ED9-876D-D9032F1A8DAFQ35528811-90DC46CE-EA7C-46A3-8A6D-2CB6A3519D72Q35864299-928204C7-8947-4427-A58B-888FDA122AD0Q35975846-89393A7E-8C23-49D2-970B-E79A12D6F676Q35976459-849671FC-E0C9-4090-817C-B92425F5B715Q36081293-5AD7C94F-EC4D-439F-A12B-82DEF20D1A64Q36278394-C87067B8-6B8B-4384-8365-109CFEC2AB72Q36642208-8533E866-F210-4863-9C47-26EF5AEE1305Q36901910-327B6DF1-2BE0-4A87-923E-3A9F9208E05FQ37924325-0AE121C1-8103-4053-942A-0C782CA4E0B8Q38940463-487D2D7A-EBF9-416C-A645-6ED87E29D1DBQ39718889-E3B4C14E-7630-4640-9387-BC0D5CF97E27Q39726480-C0A6020D-8042-4F45-87CC-E2BC5A895B14Q40343588-C6FA8393-DA43-449B-8477-1BF805053F96Q41370400-BFD8CD5D-9785-46C0-8217-93221713B0C6Q41581051-4A67920C-F0AA-44EE-BA82-532859824202Q41813125-B69DE4C0-0F8A-4CD0-BA36-3673A66A2042Q41898403-1D341FDF-062D-4CEB-8171-7CE1AC6A5D27Q42084592-A84D4C28-91C0-4DAC-B153-F9417DE95173Q42142955-50842CFC-D785-459D-A5F2-6EF68AE336BFQ42276050-3F565A12-EE93-4E99-84E9-D34F871F45C1Q42805206-E71A009B-E1E3-4311-AB2B-A949C1144BF5Q42827768-CF5C248B-5B31-4C0C-89E0-68B9B1AAAEFAQ43598709-F05B3502-9388-4515-95F9-2870272DD446Q43744117-C5DBDCC3-F733-4F63-9D36-E02F44B261A7Q43994812-E0ED7AE0-1070-495B-B1E5-4E1ACB625B93Q51015339-5D3E7612-4319-4E2F-9B08-6D337A250478Q51563511-F4E616AD-32EF-4B07-9F83-34C67704BC6EQ54400557-4CD1CC16-CF22-46F3-821C-A8077F6F8674Q57701627-B6E78B3A-D4DC-4392-8E28-7E34C75EA9D5
P2860
Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Early development of protein m ...... el system for cancer cachexia.
@en
Early development of protein m ...... el system for cancer cachexia.
@nl
type
label
Early development of protein m ...... el system for cancer cachexia.
@en
Early development of protein m ...... el system for cancer cachexia.
@nl
prefLabel
Early development of protein m ...... el system for cancer cachexia.
@en
Early development of protein m ...... el system for cancer cachexia.
@nl
P2093
P2860
P356
P1433
P1476
Early development of protein m ...... el system for cancer cachexia.
@en
P2093
Baccino FM
Tessitore L
P2860
P304
P356
10.1042/BJ2410153
P407
P577
1987-01-01T00:00:00Z